Olson Scott
SEC CIK 1816850 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | SVP, Pres, Rhythm Management | 14.5K | — | $121.4K | 14 | 2021-07-01 | 2022-04-01 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Olson Scott made no open-market trades at BSX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-01 | 2022-04-01 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | S - Sale | $44.55 | -700 | 14.5K | -5% | -$31.2K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,426 | 16.0K | +10% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $44.17 | -766 | 15.2K | -5% | -$33.8K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,090 | 15.2K | +8% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $42.55 | -606 | 14.6K | -4% | -$25.8K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +2,453 | 14.3K | +21% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $42.71 | -1,223 | 13.5K | -8% | -$52.2K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,292 | 13.6K | +11% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $44.01 | -707 | 12.8K | -5% | -$31.1K |
| 2022-01-04 | 2022-01-03 | BSX | Boston Scientific | Olson Scott | SVP, Pres, CRM, Diagnostics | S - Sale | $42.59 | -700 | 12.1K | -5% | -$29.8K | |
| 2021-10-04 | 2021-10-01 | BSX | Boston Scientific | Olson Scott | SVP, Pres, Rhythm Management | S - Sale | $43.49 | -700 | 12.8K | -5% | -$30.4K | |
| D | 2021-07-06 | 2021-07-01 | BSX | Boston Scientific | Olson Scott | SVP, Pres, Rhythm Management | M - OptEx | $0.00 | +1,771 | 14.6K | +14% | $0 |
| D | 2021-07-06 | 2021-07-01 | BSX | Boston Scientific | Olson Scott | SVP, Pres, Rhythm Management | F - Tax | $43.36 | -874 | 13.0K | -6% | -$37.9K |
| D | 2021-07-06 | 2021-07-01 | BSX | Boston Scientific | Olson Scott | SVP, Pres, Rhythm Management | S - Sale+OE | $42.78 | -700 | 13.9K | -5% | -$29.9K |
Purchase Sale Sale after option exercise All abbreviations